| Code | Description | Claims | Beneficiaries | Total Paid |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,221 |
2,926 |
$154K |
| 36415 |
Collection of venous blood by venipuncture |
1,157 |
970 |
$49K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
496 |
467 |
$41K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
519 |
480 |
$37K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
619 |
571 |
$33K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,124 |
1,027 |
$27K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
138 |
131 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
129 |
124 |
$24K |
| 86706 |
|
109 |
104 |
$21K |
| 87340 |
|
103 |
98 |
$21K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
117 |
112 |
$21K |
| 86803 |
|
134 |
128 |
$20K |
| 86780 |
|
98 |
94 |
$17K |
| 86704 |
|
76 |
74 |
$15K |
| 87505 |
|
80 |
25 |
$15K |
| 86787 |
|
61 |
61 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
326 |
319 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
102 |
28 |
$12K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
98 |
26 |
$12K |
| 86708 |
|
46 |
46 |
$9K |
| 80061 |
Lipid panel |
210 |
199 |
$8K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
33 |
12 |
$6K |
| 87209 |
|
43 |
14 |
$6K |
| 87177 |
|
43 |
14 |
$6K |
| 80053 |
Comprehensive metabolic panel |
74 |
73 |
$5K |
| 87631 |
|
15 |
13 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
57 |
56 |
$3K |
| 81001 |
|
18 |
17 |
$2K |
| 96127 |
|
157 |
155 |
$1K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
12 |
12 |
$612.33 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
107 |
91 |
$462.42 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
24 |
24 |
$442.84 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
12 |
12 |
$395.67 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$284.82 |